Alteogen Inc.
Biotech firm developing next-gen ADCs and biobetters with proprietary platform technologies.
196170 | KO
Overview
Corporate Details
- ISIN(s):
- KR7196170005
- LEI:
- Country:
- South Korea
- Address:
- 대전광역시 유성구 유성대로1628번길 62 (전민동 461-38번지), 대전광역시
- Website:
- http://www.alteogen.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Alteogen Inc. is a biotechnology company focused on the research and development of next-generation biopharmaceuticals, including long-acting biobetters, antibody-drug conjugates (ADCs), and biosimilars. The company leverages a portfolio of proprietary platform technologies to improve existing biologic therapies. Its core technologies include Hybrozyme™, which enables the conversion of intravenous formulations to subcutaneous injections for enhanced patient convenience; NexP™ Fusion, a technology for creating long-acting biologics; and NexMab™, an ADC platform designed for superior stability and efficacy. Through these innovations, Alteogen aims to deliver therapies with enhanced efficacy, durability, and safety profiles.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-10 00:00 |
Report Publication Announcement
기업설명회(IR)개최
|
Korean | 6.7 KB | ||
| 2025-08-13 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 2.1 MB | ||
| 2025-05-21 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.2 KB | ||
| 2025-05-13 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 2.1 MB | ||
| 2025-04-30 00:00 |
Regulatory News Service
소속부변경
|
Korean | 3.6 KB | ||
| 2025-04-03 00:00 |
M&A Activity
회사합병결정(종속회사의주요경영사항)
|
Korean | 19.8 KB | ||
| 2025-04-03 00:00 |
M&A Activity
타법인주식및출자증권취득결정
|
Korean | 16.6 KB | ||
| 2025-04-03 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 117.7 KB | ||
| 2025-03-31 00:00 |
Post-Annual General Meeting Information
정기주주총회결과
|
Korean | 25.6 KB | ||
| 2025-03-31 00:00 |
Share Issue/Capital Change
주식매수선택권부여에관한신고
|
Korean | 15.1 KB | ||
| 2025-03-26 00:00 |
Report Publication Announcement
기업설명회(IR)개최
|
Korean | 6.7 KB | ||
| 2025-03-21 00:00 |
Audit Report / Information
감사보고서제출
|
Korean | 25.1 KB | ||
| 2025-03-21 00:00 |
Audit Report / Information
사업보고서 (2024.12)
|
Korean | 583.5 KB | ||
| 2025-03-17 00:00 |
Regulatory News Service
투자판단관련주요경영사항 (인간 히알루로니다제 원천 기술(ALT-B4) 독점적 라이선스 계약 체결)
|
Korean | 11.2 KB | ||
| 2025-03-17 00:00 |
Regulatory News Service
투자판단관련주요경영사항 (인간 히알루로니다제 원천 기술(ALT-B4) 독점적 라이선스 계약 체결)
|
Korean | 11.2 KB |
Automate Your Workflow. Get a real-time feed of all Alteogen Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Alteogen Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Alteogen Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
%20Inc./other/Mind_Medicine_MindMed_Inc.-logo.png){kind=logo}
